CLCZ696B2319E1 OL Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate long-term safety and tolerability data in eligible
CLCZ696B2319 (PANORAMA-HF) patients receiving open-label sacubitril/valsartan.